192 related articles for article (PubMed ID: 17898866)
1. Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.
Matarasso N; Bar-Shira A; Rozovski U; Rosner S; Orr-Urtreger A
Neoplasia; 2007 Sep; 9(9):707-15. PubMed ID: 17898866
[TBL] [Abstract][Full Text] [Related]
2. Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers.
Hienonen T; Salovaara R; Mecklin JP; Järvinen H; Karhu A; Aaltonen LA
Int J Cancer; 2006 Jan; 118(2):505-8. PubMed ID: 16049965
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H; Rickman DS; Park K; Chae SS; Sboner A; MacDonald TY; Wang Y; Sheikh KL; Terry S; Tagawa ST; Dhir R; Nelson JB; de la Taille A; Allory Y; Gerstein MB; Perner S; Pienta KJ; Chinnaiyan AM; Wang Y; Collins CC; Gleave ME; Demichelis F; Nanus DM; Rubin MA
Cancer Discov; 2011 Nov; 1(6):487-95. PubMed ID: 22389870
[TBL] [Abstract][Full Text] [Related]
5. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
Mosquera JM; Beltran H; Park K; MacDonald TY; Robinson BD; Tagawa ST; Perner S; Bismar TA; Erbersdobler A; Dhir R; Nelson JB; Nanus DM; Rubin MA
Neoplasia; 2013 Jan; 15(1):1-10. PubMed ID: 23358695
[TBL] [Abstract][Full Text] [Related]
6. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.
Chen MW; Vacherot F; De La Taille A; Gil-Diez-De-Medina S; Shen R; Friedman RA; Burchardt M; Chopin DK; Buttyan R
Oncogene; 2002 Nov; 21(51):7861-71. PubMed ID: 12420223
[TBL] [Abstract][Full Text] [Related]
7. Common genetic polymorphisms of AURKA and prostate cancer risk.
Feik E; Baierl A; Madersbacher S; Schatzl G; Maj-Hes A; Berges R; Micksche M; Gsur A
Cancer Causes Control; 2009 Mar; 20(2):147-52. PubMed ID: 18802780
[TBL] [Abstract][Full Text] [Related]
8. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.
Chieffi P; Cozzolino L; Kisslinger A; Libertini S; Staibano S; Mansueto G; De Rosa G; Villacci A; Vitale M; Linardopoulos S; Portella G; Tramontano D
Prostate; 2006 Feb; 66(3):326-33. PubMed ID: 16267859
[TBL] [Abstract][Full Text] [Related]
9. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
11. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
12. Targeting Aurora kinases for the treatment of prostate cancer.
Lee EC; Frolov A; Li R; Ayala G; Greenberg NM
Cancer Res; 2006 May; 66(10):4996-5002. PubMed ID: 16707419
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
[TBL] [Abstract][Full Text] [Related]
14. Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Transl Med; 2011 Jun; 9():100. PubMed ID: 21718475
[TBL] [Abstract][Full Text] [Related]
15. AURKA Phe31Ile polymorphism interacted with use of alcohol, betel quid, and cigarettes at multiplicative risk of oral cancer occurrence.
Lee CP; Chiang SL; Lee CH; Tsai YS; Wang ZH; Hua CH; Chen YC; Tsai EM; Ko YC
Clin Oral Investig; 2015 Nov; 19(8):1825-32. PubMed ID: 25697104
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.
Bainbridge MN; Warren RL; Hirst M; Romanuik T; Zeng T; Go A; Delaney A; Griffith M; Hickenbotham M; Magrini V; Mardis ER; Sadar MD; Siddiqui AS; Marra MA; Jones SJ
BMC Genomics; 2006 Sep; 7():246. PubMed ID: 17010196
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
18. Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death.
Hamidi T; Cano CE; Grasso D; Garcia MN; Sandi MJ; Calvo EL; Dagorn JC; Lomberk G; Urrutia R; Goruppi S; Carracedo A; Velasco G; Iovanna JL
Clin Cancer Res; 2012 Oct; 18(19):5234-46. PubMed ID: 22899799
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians.
Gu J; Gong Y; Huang M; Lu C; Spitz MR; Wu X
Carcinogenesis; 2007 Feb; 28(2):350-5. PubMed ID: 16926177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
